相似文献
1
Central role of the P2Y12 receptor in platelet activation.
J Clin Invest. 2004 Feb;113(3):340-5. doi: 10.1172/JCI20986.
2
P2Y12 receptor in platelet activation.
Platelets. 2011;22(1):56-60. doi: 10.3109/09537104.2010.497231.
3
P2 receptors and platelet activation.
ScientificWorldJournal. 2002 Feb 13;2:424-33. doi: 10.1100/tsw.2002.106.
4
Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation.
J Thromb Haemost. 2005 May;3(5):1036-41. doi: 10.1111/j.1538-7836.2005.01325.x.
5
The role of ADP receptors in platelet function.
Front Biosci. 2006 May 1;11:1977-86. doi: 10.2741/1939.
6
The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Br J Haematol. 2000 Sep;110(4):925-34. doi: 10.1046/j.1365-2141.2000.02208.x.
7
The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
Platelets. 2010;21(2):85-93. doi: 10.3109/09537100903470298.
8
Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets.
Blood. 2004 Sep 15;104(6):1745-52. doi: 10.1182/blood-2004-02-0534. Epub 2004 Jun 8.
9
Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses.
Blood. 2004 Sep 1;104(5):1335-43. doi: 10.1182/blood-2004-01-0069. Epub 2004 May 13.
10
Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation.
Br J Pharmacol. 2004 Aug;142(8):1325-31. doi: 10.1038/sj.bjp.0705885. Epub 2004 Jul 20.
引用本文的文献
1
Preclinical Efficacy of a Hemostatic Agent in Overcoming Dual Antiplatelet Therapy.
JACC Basic Transl Sci. 2025 Aug 15;10(9):101356. doi: 10.1016/j.jacbts.2025.101356.
2
Platelet-Related Biomarkers and Efficacy of Antiplatelet Therapy in Patients with Aortic Stenosis and Coronary Artery Disease.
Int J Mol Sci. 2025 Jul 23;26(15):7083. doi: 10.3390/ijms26157083.
3
A narrative review of research advancements in pharmacogenetics of cardiovascular disease and impact on clinical implications.
NPJ Genom Med. 2025 Jul 10;10(1):54. doi: 10.1038/s41525-025-00511-6.
4
Effect of Alternative Administrations on P2Y12 Receptor Inhibitors' Pharmacokinetics and Pharmacodynamics: Systematic Review and Meta-Analysis.
AAPS J. 2025 Jun 18;27(5):110. doi: 10.1208/s12248-025-01095-w.
5
Inhibitory Effect of Clopidogrel, a P2Y Receptor Antagonist, on Hematogenic Metastasis in B16-BL6 Mouse Melanoma Cells.
In Vivo. 2025 May-Jun;39(3):1325-1330. doi: 10.21873/invivo.13936.
6
Elderly patients are hyperresponsive to potent P2Y12 inhibitors.
Res Pract Thromb Haemost. 2025 Feb 20;9(2):102704. doi: 10.1016/j.rpth.2025.102704. eCollection 2025 Feb.
7
The profile of inflammatory extracellular vesicles in intracerebral hemorrhage patients.
Front Stroke. 2022;1. doi: 10.3389/fstro.2022.988081. Epub 2022 Sep 19.
8
The Effect of Colchicine on Platelet Function Profiles in Patients with Stable Coronary Artery Disease: The ECLIPSE Pilot Study.
Cardiol Ther. 2025 Mar;14(1):87-100. doi: 10.1007/s40119-024-00393-2. Epub 2025 Jan 18.
9
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.
Nat Rev Drug Discov. 2025 Apr;24(4):251-275. doi: 10.1038/s41573-024-01083-3. Epub 2025 Jan 2.
10
Sustainable Immunomodulatory via Macrophage P2Y12 Inhibition Mediated Bioactive Patche for Peritendinous Antiadhesion.
Adv Sci (Weinh). 2025 Jan;12(4):e2409128. doi: 10.1002/advs.202409128. Epub 2024 Dec 4.
本文引用的文献
1
Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses.
Blood. 2004 Sep 1;104(5):1335-43. doi: 10.1182/blood-2004-01-0069. Epub 2004 May 13.
2
Akt activation in platelets depends on Gi signaling pathways.
J Biol Chem. 2004 Feb 6;279(6):4186-95. doi: 10.1074/jbc.M306162200. Epub 2003 Nov 17.
3
ADP receptors--targets for developing antithrombotic agents.
Curr Pharm Des. 2003;9(28):2303-16. doi: 10.2174/1381612033453947.
4
Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
Circulation. 2003 Aug 26;108(8):921-4. doi: 10.1161/01.CIR.0000088780.57432.43. Epub 2003 Aug 18.
5
Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis.
Curr Opin Hematol. 2003 Sep;10(5):333-8. doi: 10.1097/00062752-200309000-00002.
6
P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.
J Clin Invest. 2003 Aug;112(3):398-406. doi: 10.1172/JCI17864.
7
Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies.
Am J Cardiol. 2003 Aug 1;92(3):285-8. doi: 10.1016/s0002-9149(03)00626-x.
8
Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist.
J Thromb Haemost. 2003 Jun;1(6):1144-9. doi: 10.1046/j.1538-7836.2003.00144.x.
9
Signaling events underlying thrombus formation.
J Thromb Haemost. 2003 Jul;1(7):1602-12. doi: 10.1046/j.1538-7836.2003.00267.x.
10
Dynamic regulation of microtubule coils in ADP-induced platelet shape change by p160ROCK (Rho-kinase).
Platelets. 2003 May;14(3):159-69. doi: 10.1080/0953710031000092794.
Zotero 插件